Browsing by Author "J Oldenburg"
Now showing 1 - 5 of 5
- Results Per Page
- Sort Options
Item Bleeding events and safety outcomes in persons with haemophilia A with inhibitors A prospective multicentre noninterventional studyJohnny Mahlangu; J Oldenburg; Michael Callaghan; Midori Shima; Elena Santagostino; E et alItem Emicizumab is well tolerated and effective in people with congenital haemophila A regardless of age severity of disease or inhibitor status a scoping review(WILEY-BLACKWELL) G Young; S Pipe; G Kenet; J Oldenburg; E et al; Johnny MahlanguItem Healthrelated quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors A non interventional studyJ Oldenburg; Huyen Tran; Flora Peyvandi; Ramiro Nunez; Peter Trask; S Chebon; Johnny Mahlangu; M Lehle; V JIMENEZ-YUSTE; S Von MackensenItem Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion proteinJ Oldenburg; R Kulkarni; A SRIVASTAVA; Johnny Mahlangu; V BLANCHETTE; E et alItem Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1 2 or 4 weeksA Kiialainen; J I Adamkewicz; C Petry; J Oldenburg; E et al; Johnny Mahlangu